RNA virus sequencing relies on platforms that generally read DNA, so viral RNA is converted into complementary DNA, or cDNA. This creates a DNA-based template that can then be amplified or incorporated into a sequencing library. Without this conversion, the RNA genome would not enter the stated DNA-reading workflow.
Reference-based analysis aligns generated sequencing reads with an existing viral genome, allowing researchers to compare the sample with a known sequence. De novo assembly instead reconstructs sequence information without relying on a reference genome. Using either approach helps produce an interpretable viral sequence while supporting identification of related strains and genetic changes.
Comparing viral sequences reveals mutations and helps distinguish related strains. When sequences from multiple samples are examined, their similarities and differences can also reveal transmission patterns. In medicine, these findings support surveillance of emerging variants, evaluation of diagnostic targets, and broader interpretation of how viral populations change during outbreaks.
The workflow begins with viral RNA, followed by reverse transcription to produce complementary DNA. That material is then amplified or prepared as a sequencing library before sequencing generates reads. Finally, the reads are aligned to a reference genome or assembled de novo, producing sequence information that can be examined for species identity, mutations, and strain relationships.
During an outbreak, sequencing can identify the viral species involved, distinguish related strains, and reveal transmission patterns across samples. These results add genetic evidence to outbreak surveillance and help monitor emerging variants. The information can therefore support public health responses while also guiding research into the changing viral population.
Sequence data can help assess diagnostic targets by showing which viral regions are present and how they vary. The same information supports research on treatment, vaccine development, and emerging variants. Because sequencing also distinguishes viral strains, it connects laboratory genetic findings with medical surveillance and investigations of disease spread.